Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA:688336)
China · Delayed Price · Currency is CNY 47.65
-0.96 (-1.97%)
Aug 21, 2026, 3:00 PM CST
SHA:688336 Revenue
Sunshine Guojian Pharmaceutical (Shanghai) had revenue of 434.47M CNY in the quarter ending June 30, 2026, with 31.30% growth. This brings the company's revenue in the last twelve months to 4.42B, up 256.98% year-over-year. In the year 2025, Sunshine Guojian Pharmaceutical (Shanghai) had annual revenue of 4.20B with 251.81% growth.
Revenue (ttm)
4.42B
Revenue Growth
+256.98%
P/S Ratio
9.66
Revenue / Employee
4.37M
Employees
1,012
Market Cap
42.71B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.20B | 3.01B | 251.81% |
| Dec 31, 2024 | 1.19B | 179.53M | 17.70% |
| Dec 31, 2023 | 1.01B | 188.54M | 22.84% |
| Dec 31, 2022 | 825.49M | -103.32M | -11.12% |
| Dec 31, 2021 | 928.81M | 273.80M | 41.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.